|
|
Papers Published
- EC Dietze, MM Troch, ML Bowie, L Yee, GR Bean, VL Seewaldt, CBP/p300 induction is required for retinoic acid sensitivity in human mammary cells.,
Biochemical and biophysical research communications, United States, vol. 302 no. 4
(March, 2003),
pp. 841-8, ISSN 0006-291X [abs]
- LD Yee, Y Guo, J Bradbury, S Suster, SK Clinton, VL Seewaldt, The antiproliferative effects of PPARgamma ligands in normal human mammary epithelial cells.,
Breast cancer research and treatment, Netherlands, vol. 78 no. 2
(March, 2003),
pp. 179-92, ISSN 0167-6806 [abs]
- EC Dietze, LE Caldwell, K Marcom, SJ Collins, L Yee, K Swisshelm, KB Hobbs, GR Bean, VL Seewaldt, Retinoids and retinoic acid receptors regulate growth arrest and apoptosis in human mammary epithelial cells and modulate expression of CBP/p300.,
Microscopy research and technique, United States, vol. 59 no. 1
(October, 2002),
pp. 23-40, ISSN 1059-910X [abs]
- PM Treuting, LI Chen, BS Buetow, W Zeng, TA Birkebak, VL Seewaldt, KM Sommer, M Emond, L Maggio-Price, K Swisshelm, Retinoic acid receptor beta2 inhibition of metastasis in mouse mammary gland xenografts.,
Breast cancer research and treatment, Netherlands, vol. 72 no. 1
(March, 2002),
pp. 79-88, ISSN 0167-6806 [abs]
- VL Seewaldt, K Mrózek, R Sigle, EC Dietze, K Heine, DM Hockenbery, KB Hobbs, LE Caldwell, Suppression of p53 function in normal human mammary epithelial cells increases sensitivity to extracellular matrix-induced apoptosis.,
The Journal of cell biology, United States, vol. 155 no. 3
(October, 2001),
pp. 471-86, ISSN 0021-9525 [abs]
- EC Dietze, L Yee, VL Seewaldt, Suppression of pRB expression in normal human mammary epithelial cells is associated with resistance to all-trans-retinoic acid but not N-(4-hydroxylphenyl)-retinamide.,
Breast cancer research and treatment, Netherlands, vol. 66 no. 1
(March, 2001),
pp. 41-50, ISSN 0167-6806 [abs]
- EC Dietze, LE Caldwell, SL Grupin, M Mancini, VL Seewaldt, Tamoxifen but not 4-hydroxytamoxifen initiates apoptosis in p53(-) normal human mammary epithelial cells by inducing mitochondrial depolarization.,
The Journal of biological chemistry, United States, vol. 276 no. 7
(February, 2001),
pp. 5384-94, ISSN 0021-9258 [abs]
- VL Seewaldt, K Mrózek, EC Dietze, M Parker, LE Caldwell, Human papillomavirus type 16 E6 inactivation of p53 in normal human mammary epithelial cells promotes tamoxifen-mediated apoptosis.,
Cancer research, United States, vol. 61 no. 2
(January, 2001),
pp. 616-24, ISSN 0008-5472 [abs]
- VL Seewaldt, JH Kim, MB Parker, EC Dietze, KV Srinivasan, LE Caldwell, Dysregulated expression of cyclin D1 in normal human mammary epithelial cells inhibits all-trans-retinoic acid-mediated G0/G1-phase arrest and differentiation in vitro.,
Experimental cell research, UNITED STATES, vol. 249 no. 1
(May, 1999),
pp. 70-85, ISSN 0014-4827 [abs]
- VL Seewaldt, EC Dietze, BS Johnson, SJ Collins, MB Parker, Retinoic acid-mediated G1-S-phase arrest of normal human mammary epithelial cells is independent of the level of p53 protein expression.,
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research, UNITED STATES, vol. 10 no. 1
(January, 1999),
pp. 49-59, ISSN 1044-9523 [abs]
- 3) Seewaldt, V.L., Kim, J.-h., Dietze, E.C., and Caldwell, L.E. Dysregulated expression of cyclin D1 inhibits retinoid-mediated G1/S-phase arrest and differentiation of normal human mammary epithelial cells. Experimental Cell Res. 249:70-85, 1999.
- VL Seewaldt, JM Cain, BA Goff, H Tamimi, B Greer, D Figge, A retrospective review of paclitaxel-associated gastrointestinal necrosis in patients with epithelial ovarian cancer.,
Gynecologic oncology, UNITED STATES, vol. 67 no. 2
(November, 1997),
pp. 137-40, ISSN 0090-8258 [abs]
- VL Seewaldt, LE Caldwell, BS Johnson, K Swisshelm, SJ Collins, S Tsai, Inhibition of retinoic acid receptor function in normal human mammary epithelial cells results in increased cellular proliferation and inhibits the formation of a polarized epithelium in vitro.,
Experimental cell research, UNITED STATES, vol. 236 no. 1
(October, 1997),
pp. 16-28, ISSN 0014-4827 [abs]
- VL Seewaldt, JH Kim, LE Caldwell, BS Johnson, K Swisshelm, SJ Collins, All-trans-retinoic acid mediates G1 arrest but not apoptosis of normal human mammary epithelial cells.,
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research, UNITED STATES, vol. 8 no. 6
(June, 1997),
pp. 631-41, ISSN 1044-9523 [abs]
- 1) Seewaldt, V.L., Caldwell, L.E., Johnson, B.S., Swisshelm, K., and Collins, S.J. All-trans-retinoic acid regulates G1 arrest but not apoptosis of normal human mammary epithelial cells. Cell Growth and Diff. 8:631-641, 1997.
- 2) Seewaldt, V.L., Caldwell, L.E., Johnson, B.S., Swisshelm, K., Collins, S.J., and Tsai, S. Inhibition of retinoic acid receptor function in normal human mammary epithelial cells results in increase proliferation and inhibition of the formation of a polarized epithelium in vitro. Experimental Cell Research. 236:16-28, 1997.
- VL Seewaldt, BS Johnson, MB Parker, SJ Collins, K Swisshelm, Expression of retinoic acid receptor beta mediates retinoic acid-induced growth arrest and apoptosis in breast cancer cells.,
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research, UNITED STATES, vol. 6 no. 9
(September, 1995),
pp. 1077-88, ISSN 1044-9523 [abs]
- VL Seewaldt, JM Cain, BE Greer, HK Tamimi, DC Figge, RB Livingston, Reviving the pelvic examination for evaluating the status of ovarian carcinoma.,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, UNITED STATES, vol. 13 no. 3
(March, 1995),
pp. 799, ISSN 0732-183X
- VL Seewaldt, DC Figge, BE Greer, HK Tamimi, WS Brown, JM Cain, Primary central nervous system recurrence after paclitaxel therapy for epithelial ovarian malignancy.,
Gynecologic oncology, UNITED STATES, vol. 55 no. 3 Pt 1
(December, 1994),
pp. 456-8, ISSN 0090-8258 [abs]
- VL Seewaldt, BE Greer, JM Cain, DC Figge, HK Tamimi, WS Brown, SA Miller, Paclitaxel (Taxol) treatment for refractory ovarian cancer: phase II clinical trial.,
American journal of obstetrics and gynecology, UNITED STATES, vol. 170 no. 6
(June, 1994),
pp. 1666-70; discussion 1670-1, ISSN 0002-9378 [abs]
|